No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Cosciens Biopharma Down 3.3% As Repositions as Life Sciences Business
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
Cosciens Biopharma Inc: INTERIM MDA EN
Cosciens Biopharma Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director
Cosciens Biopharma Hires Recruiting Firm to Find Next CEO, Says Integration of Ceapro Progressing
No Data